Navigation Links
Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
Date:4/26/2012

eadquarters is an excellent example of the partnership between the Georgia Department of Economic Development, Metro Atlanta Chamber, and the City of Dunwoody to cultivate new business for Georgia," said Economic Development Director Michael Starling. "Elekta is a true reflection of the state's and Dunwoody's strategy to recruit and grow world-class technology companies."

"The decision by Elekta to establish its North American headquarters in Dunwoody is the culmination of a truly collaborative and creative effort," said Jeff Estep, executive managing director of Newmark Knight Frank, the consultant to Elekta. "We conducted a thorough analysis of Elekta's needs and location options across North America, including in-depth review of business costs, talent availability, training and operational processes, and the Atlanta area proved itself to be the ideal location for the company's global growth objectives. We received incredible support from the State of Georgia, DeKalb County, the City of Dunwoody and the Metro Atlanta Chamber."

Elekta develops sophisticated tools and dose planning systems for radiation therapy and radiosurgery and brachytherapy, in addition to software systems that improve the efficiency of workflows throughout the spectrum of cancer care. Among its most recognized products are Elekta Synergy®, Elekta Infinity™ and Elekta Axesse™ radiation treatment systems (linear accelerators), Leksell Gamma Knife® Perfexion™ radiosurgery system for ultra-precise treatment of intracranial disease targets, MOSAIQ® oncology information system and Monaco® treatment planning system.

Employing about 3,300 people globally, Elekta markets its solutions in North and South America, Europe, the Middle East, Africa and Asia-Pacific countries.

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email:

SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
2. NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
3. Stem Cell Pioneer to Speak to A.L.L. Personhood Conference
4. Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
5. Pioneering Brain Malformation Treatment Performed Using Novalis Tx(TM) Radiosurgery Technology in India
6. Fora Care Group Becomes Pioneering Educational Member of the International Society of Vascular Health
7. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
8. The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
9. Pioneer(R) Surgical Technology, Inc. Announces New Expansion Plan
10. Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design
11. Pioneer(R) Surgical Technology, Inc. and Bonovo(R) Orthopedics, Inc. Establish Foothold in Fastest Growing Spine Market in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... China separating membrane market has witnessed robust development ... years, albeit as a later starter. In 2012, the size ... approximated RMB12 billion, with the proportion worldwide soaring to 16.3%. ... membrane market will continue its growth rate by around 20% ... will jump to roughly RMB25 billion. An integrated ...
(Date:12/17/2014)... , Dec. 17, 2014  Northstar Global Business ... Trust Company (DTC) has made their final decision ... on the Company,s stock effective December 15, 2014, ... stock for depository and book entry transfer services. All ... is now once again fully "DTC Eligible", and ...
(Date:12/17/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or ... of $125 million aggregate principal amount of 3.75% Convertible ... offered and sold only to qualified institutional buyers pursuant ... as amended (the "Securities Act"). The Notes ... year, payable semiannually in arrears on June 15 and ...
Breaking Medicine Technology:Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... plc , (LSE: SHP, Nasdaq: SHPGY ), the ... and Drug Administration (FDA) approved the use of once-daily ... for the treatment of attention deficit hyperactivity disorder (ADHD) in ... a total treatment program. The approval is based on results ...
... YORK, Feb. 28, 2011 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... the Company,s Chief Executive Officer, will be presenting at ... Conference (New York, NY)Wednesday, March 2, 201111:00am ETCowen & ... MA)Monday, March 7, 2011 4:45pm ETROTH 23rd Annual OC ...
Cached Medicine Technology:FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 2FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 3FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 4FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 5FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents 6Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations 2
(Date:12/21/2014)... 21, 2014 AngelWeddingDress.com’s new collection of ... a total of 1,000 new designs in this collection, ... spring 2015. , AngelWeddingDress.com promises to provide ... with wardrobe essentials while many fashion trends come and ... customer service team at AngelWeddingDress.com is ready to assist. ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Recently, one ... world, LunaDress Prom Shop has introduced its ... Christmas Sale, offering big discounts on all its prom ... off. , LunaDress insists on providing top quality dress ... and it is considered as one of the best ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Serious Buyer, ... for Vintage 1967 Jm Morrison and the Doors International Ballroom ... This would also be the only time that Morrison's ... was on Nov. 25, 1967. According to Hawley, “This ... They did play the Alexandria Roller Rink earlier that ...
(Date:12/21/2014)... 2014 SCI explores disability ... and systemic barriers for disabled athletes with Aaron ... has a condition called juvenile macular degeneration, where he ... he adapted his athletic ambitions to his vision and ... triathlon to pioneer the way for other blind and ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 CannabisClassifieds.com celebrates marijuana’s ... The only one of its kind, the site has ... local marijuana for 14 years running. It uniquely combines ... to make cannabis readily available to the masses. Assuring ... grasping the golden ring of public approval. , ...
Breaking Medicine News(10 mins):Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2
... diet, researchers say , WEDNESDAY, July 8 (HealthDay News) -- ... common amino acids in vegetable protein seems to lower blood ... shows that a 4.72 percent higher intake of glutamic acid ... 1.5- to 3-point reduction in average systolic blood pressure (the ...
... 8 Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: ... non-invasive, topically administered products, today announced they have ... pivotal Phase 3 clinical study for Ketotransdel(R), a ... acute pain. , , Based on ...
... N.Y., July 8 The Max Cure Foundation -- a ... -- announced today its first charity benefit, the first annual ... take place on Saturday, August 22, from 2:00 - 6:00 ... the East Hampton Indoor Tennis Club, 175 Daniels Hole Road, ...
... July 8 Perot Systems Corporation (NYSE: ... an agreement with the Hunan Provincial Government of the ... to provide IT consulting services for healthcare organizations and ... the Provincial Government and in alignment with the Chinese ...
... ... High Definition videoconferencing, audiovisual (AV), networked solutions and services to offer video conferencing ... global room affiliates. , ... Denver, CO and Camarillo, CA (PRWEB) July 8 -- Affinity ...
... ... popularity. These parts washers are cost effective and quick solutions for companies that need ... ... Midbrook, a Jackson, MI based manufacturer of industrial parts washing systems, medical decontamination systems, ...
Cached Medicine News:Health News:Vegetable Amino Acid Lowers Blood Pressure 2Health News:Vegetable Amino Acid Lowers Blood Pressure 3Health News:Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment 2Health News:Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment 3Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 2Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 3Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 4Health News:The Max Cure Foundation Announces Its First Charity Benefit: The 'Roar for a Cure' Carnival to Be Held on Saturday, August 22, 2009 5Health News:Perot Systems Selected to Implement Health Information Systems in China 2Health News:Perot Systems Selected to Implement Health Information Systems in China 3Health News:Affinity VideoNet Partners With Providea Conferencing 2Health News:Affinity VideoNet Partners With Providea Conferencing 3Health News:Refurbished and Used Industrial Parts Washers Grow in Popularity 2
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
... continues the "Consensus Concept" approach to design ... experience of a Scientific Advisory Board. The ... incorporates state-of-the-art features. Consensus Knee implants are ... stability and allow near normal kinematics. The ...
Medicine Products: